FDA Inspection
Imprimis NJOF, LLCImprimis NJOF, LLC – FDA Inspection, Apr 3, 2024
Record Details
This FDA Inspection record concerns Imprimis NJOF, LLC, with an inspection on April 3, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6ccdf0f4-5b8b-4f85-ae41-5531cf4b6475
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1231238
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Imprimis NJOF, LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| August 18, 2026 | Not classified | New Jersey District Office | |
| January 29, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 10, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Imprimis NJOF, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.